Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision. At such a critical moment in ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

But now, a growing number of lawsuits claim that Ozempic causes vision loss in some patients. RELATED: Ozempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason Why.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The lawsuits allege that Ozempic causes a rare eye condition called NAION, or non-arteritic anterior ischemic optic neuropathy, which is akin to an eye stroke. All but one of the cases were filed ...

Patent and trademark enforcement has become an important economic tool for entrepreneurs.

GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide, the active ingredient in the drugs.

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.